UK MHRA response to EU pharmacovigilance proposals
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has essentially declared its support for the European Commission’s move to strengthen the current European Union pharmacovigilance system1,2, but has raised questions about some aspects of the proposals.